![]() |
14th International AIDS ConferenceBarcelona, Spain - July 7-July 12, 2002 |
Cite as: Int Conf AIDS. 2002 Jul 7-12;14:Abstract No. xx
Abstract Numbering & Table of ContentsThe abstracts have been given reference numbers as follows:
Mo = Monday, Tu = Tuesday, We = Wednesday, Th = Thursday, Lb = Late-Breaker Print only abstracts. The 2,807 printed only abstracts are identified by their special numbering, which begins with a letter A-G (signifying the track) and is followed by a 5 digit number. Tracks This track will highlight all aspects related to HIV structure and replication and its regulation as well as host immune responses. Drug discovery, research on vaccines and development of animal models will also be addressed. This track will be of particular interest to laboratory researchers and clinicians involved in basic principles of HIV. Track B: Clinical Sciences and Care This track will highlight the characteristics and clinical course of HIV infection and related diseases, the evaluation of diagnostic and therapeutic tools, including resistance tests, and the clinical trials and cohort studies which provide the scientific basis for therapeutic interventions and care. This track will be of particular interest to investigators and clinicians participating in clinical research related to HIV-1 infection. This track will highlight the description and dynamics of the evolving HIV/AIDS epidemic, the natural history and the burden and impact of HIV infection in the world. Presentations in this track will be based on both observational and experimental studies, as well as on surveillance methods. This track will be of particular interest to public health professionals, academic researchers in epidemiology or related areas, and people using epidemiologic parameters in support of HIV/AIDS programs and policies. This track will highlight the design, testing and evaluation of HIV preventive interventions for both HIV- and HIV+ persons, including those interventions addressing early diagnosis, co-factors, and risk and harm reduction. This track will also address methodological and ethical issues in HIV prevention research. This track will be of particular interest to those involved in advancing multidisciplinary (biomedical, behavioral, and social sciences) investigations of HIV prevention. This track will highlight the scientific investigation of behavioral, social, economic, political and cultural mechanisms underlying risk of, and protection from, HIV infection and AIDS, access to and continuity of care and treatment, and will assess the psychological and social impact of the epidemic on individuals, communities and society as a whole. This track will be of particular interest to people concerned with the social and economic dimensions of the epidemic who are using concepts, approaches, and frameworks derived from the well-established body of knowledge of social sciences and the methodological tools of scientific research. Interventions, Program Implementation and Policy Tracks in the Interventions, Program Implementation and Policy component (Tracks F and G) will present, discuss, and share lessons learned about programs, activities, and policies related to HIV/AIDS prevention, care, treatment, support, and impact mitigation. Component key aims are to improve understanding of factors contributing to successful and unsuccessful outcomes, to identify approaches to overcome barriers to implementing, sustaining, and scaling up effective responses to HIV/AIDS, and to develop and strengthen effective strategies for action. Track F: Interventions and Program Implementation This track will highlight planning, implementation, monitoring and evaluation of activities/programs for HIV/AIDS prevention; treatment, care and support; and impact mitigation. Sessions will focus on sharing lessons learned. This track will highlight description, analysis and lessons learned in HIV/AIDS-related advocacy and policy. The track will address both HIV/AIDS specific advocacy and policy, and related areas such as gender, human rights, economic development, and trade and patents. |